Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedUpdated page to v3.2.0 with a broad government-operating-status notice; removed a specific resource entry (Carcinoma of esophagus) from the Genetic and Rare Diseases Information Center, and retained general references to NIH/C cc and related sites.SummaryDifference3%
- Check18 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated core content: Revision updated from v3.0.1 to v3.0.2. Removed 'Back to Top' as a minor UI change.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as specific medical topics related to esophageal cancer and pembrolizumab. However, many related terms and previous location details have been removed.SummaryDifference2%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.